Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
about
Serotonin: a different player in hypertension-associated thrombosisThe antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet functionBJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX PathwayEndobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivoInhibition of platelet aggregation and thrombosis by indole alkaloids isolated from the edible insect Protaetia brevitarsis seulensis (Kolbe).Effect of serotonin on platelet function in cocaine exposed bloodUpregulation of 5-hydroxytryptamine receptor signaling in coronary arteries after organ culture.Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study.A rabbit model of thrombosis on atherosclerotic lesions.Antithrombotic and antiplatelet activities of Soshiho-tang extract.Impact of elevated plasma serotonin on global gene expression of murine megakaryocytes.Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.Effects of the 5-HT2A Antagonist Sarpogrelate on Walking Ability in Patients with Intermittent Claudication as Measured Using the Walking Impairment QuestionnaireA serotonin-induced N-glycan switch regulates platelet aggregationSerotonin uptake rates in platelets from angiotensin II-induced hypertensive mice.Controversies and future perspectives of antiplatelet therapy in secondary stroke preventionClopidogrel in acute coronary syndrome: implications of recent study findings.Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.Both 5-hydroxytryptamine 5-HT2A and 5-HT1B receptors are involved in the vasoconstrictor response to 5-HT in the human isolated internal thoracic artery.Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis.Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate.Suppression of high lipid diet induced by atherosclerosis sarpogrelate.Sarpogrelate hydrochloride, a selective 5-HT(2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease.Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.Serotonin induces vasoconstriction of smooth muscle cell-rich neointima through 5-hydroxytryptamine2A receptor in rabbit femoral arteries.Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation.Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.Antiplatelet drugs
P2860
Q27022328-B6B21243-7D3B-459A-8EA0-DDCECE8ADFE4Q28539110-3FDEC870-9D7A-4894-8D88-325990E93B8DQ28552988-F932F1FF-C52F-466F-B4BA-6AC68C410C1CQ33435199-85B4468B-98BF-4D80-83DA-AB6EB543C445Q33684221-DCC54B7A-D9EF-42BF-BB76-522DDB9A24C4Q34001485-EEDB1A80-BCD5-41C3-80FE-53AFCE6EDA78Q34156166-36753282-6FD8-42CA-A8EF-3DE7C838BA4BQ34182816-4C315001-7C39-4732-946B-0C5AC1F06D0EQ34495491-CA85A270-E1C9-45E7-8906-C39E341F312EQ34775088-DF593C3A-A224-4CB8-B4AA-582B28918B97Q34980796-2D1F9D4B-372E-4F61-90F8-69724B784724Q35892630-6E1EB655-D43C-49F1-897B-60A56614AC30Q36679155-75189AAE-05CC-4C29-A953-5A649CBC8D09Q37205659-8A0DBEF9-6EFC-4647-B839-47C87D6BBFF3Q37250033-B1735F2D-3F58-4997-B366-174A87B95CC4Q37782412-6FA95D06-8C12-4089-B99D-7FBF2278B4A6Q37786639-F2DBEB31-9B49-4AEE-8EA1-B28D99803E85Q40006101-E65C07DD-8355-465D-BEA2-D48FAD6CAA5EQ42171127-B363BD1A-F9DF-4A82-9DEF-D720D856E6DFQ42574744-667FB234-EF1B-46C1-AE87-3CB8BBAAB72BQ42687813-ACF54B46-FBB8-46F3-BF1D-047241E583E5Q42913768-75B3F3BF-1A90-4E4F-AFD5-FE6D0457D5EBQ44626515-3B21DD38-0697-4346-8259-40B0211876C8Q45961045-6A205DB9-C0FF-468E-ACC3-2B418ACB42C4Q46627647-7CB3B2FE-4B9D-4CD8-BA82-2842AB4EAA5EQ47639140-C3D11AE7-4812-49BA-A0BC-99D960015513Q48283354-4BF63621-E328-4F1D-84A1-CF147A0E8C8BQ53257546-AB797CBA-7AB2-4599-B1A6-1831AF401101Q58481433-FB662B45-35D9-4147-A4AE-118705C922BC
P2860
Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@en
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@nl
type
label
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@en
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@nl
prefLabel
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@en
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@nl
P2093
P2860
P1476
Inhibition of 5-hydroxytryptam ...... of the rabbit femoral artery.
@en
P2093
Kawamoto R
Nishihira K
Yamamoto R
Yamashita A
P2860
P304
P356
10.1111/J.1538-7836.2005.01702.X
P577
2006-01-01T00:00:00Z